✦ LIBER ✦

Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials

✍ Scribed by PonJola Coney; Ken Washenik; Richard G.B. Langley; John J. DiGiovanna; Diane D. Harrison

Book ID: 117083517
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 92 KB
Volume: 63
Category: Article
ISSN: 0010-7824
DOI: 10.1016/s0010-7824(01)00208-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-dose oral contraceptive pill for dys

Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial

✍ Tasuku Harada; Mikio Momoeda; Yuji Taketani; Hiroshi Hoshiai; Naoki Terakawa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Comparison of two dosing methods for ind

Comparison of two dosing methods for induction of response and remission with oral budesonide in active pediatric Crohn's disease: A randomized placebo-controlled trial

✍ Arie Levine; Michal Kori; Gabriel Dinari; Efrat Broide; Ron Shaoul; Baruch Yerus 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 4 views

## Background: Oral budesonide has been found to be comparable to systemic corticosteroids in mild to moderately active crohn's disease (cd). remission rates in pediatric studies to date have been suboptimal (47%-55%), even though patients with colonic involvement were excluded in some studies. in

Efficacy of a low-dose oral contraceptiv

Efficacy of a low-dose oral contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for the treatment of moderate acne: A randomized, placebo-controlled trial

✍ James Leyden; Alan Shalita; Maria Hordinsky; Leonard Swinyer; Frank Z. Stanczyk; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 191 KB